India's Glenmark to conduct trials for potential COVID-19 drug, shares jump

India's Glenmark to conduct trials for potential COVID-19 drug, shares jump
Reuters: Health
Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.


Comments

Post a Comment

Popular posts from this blog

Nadda reviews healthcare delivery mechanisms in Rajasthan, Maharashtra

The discussion centred on reinforcing public health infrastructure, improving patient-centric services, strengthening regulatory frameworks, and advancing India's commitment to eliminating tuberculosis as a public health challenge, the health ministry said in a statement. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/avQFOIc via gqrds
Read more

Women in India Report Higher Sleep Deprivation Than Men

The survey, conducted by Resmed, gathered insights from 30,000 people across 13 countries, including 5,000 respondents in India. The findings highlight a growing recognition of sleep as a health priority and underlined a persistent gaps in achieving consistent, quality rest. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/14OaF7t via gqrds
Read more

Ayush no longer at margins but at centre of global health discourse: Prataprao Jadhav

The minister made the remarks as he inaugurated and later addressed the valedictory session of the 3rd International Ayush Conference and Exhibition (IACE 2026) in Dubai, marking a major milestone in the global acceptance of traditional and integrative healthcare systems, officials said. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GOfcleq via gqrds
Read more